Qube Research & Technologies (QRT)
SBBP

Qube Research & Technologies (QRT)’s Strongbridge Biopharma plc. SBBP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,160
Closed -$107K – 3018
2021
Q2 		$107K Buy
+36,160
New +$95.5K ﹤0.01% 1940

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SBBP Position: Q3 2021 in Review

Qube Research & Technologies (QRT) sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 36,160 shares — an estimated $107K sold.

Qube Research & Technologies (QRT) first reported a position in SBBP in Q2 2021 and held it in 1 quarter. The position peaked at $107K in Q2 2021. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

  • Qube Research & Technologies (QRT) reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 36,160 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $107K.
  • Qube Research & Technologies (QRT) first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Strongbridge Biopharma plc. position peaked at $107K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2021, filed 12 Nov 2021.